Targeting Apoptosis Pathways in Cancer Therapy
2005 · CA A Cancer Journal for Clinicians · 1,331 citations
https://doi.org/10.3322/canjclin.55.3.178
A
Alex A. Adjei
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
779
Papers
38.1K
Citations
94
h-index
330
i10-index
Alex A. Adjei is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Colorectal Cancer Treatments and Studies. The author has an h-index of 94, co-authored 663 publications.
ORCID: 0009-0009-3615-5083Papers by this author
worksControl of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
2018 · Annals of the American Thoracic Society · 712 citations
https://doi.org/10.1513/annalsats.201808-564ps
Biomarker Discovery and Validation: Statistical Considerations
2021 · Journal of Thoracic Oncology · 209 citations
https://doi.org/10.1016/j.jtho.2021.01.1616
Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing
2012 · Carcinogenesis · 205 citations
https://doi.org/10.1093/carcin/bgs148
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial
2017 · The Lancet Oncology · 170 citations
https://doi.org/10.1016/s1470-2045(17)30691-5
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors
2014 · Investigational New Drugs · 56 citations
https://doi.org/10.1007/s10637-014-0167-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat